Evidence map›Paper›PMID 15716289›Full record

Trial reportBMJ (Clinical research ed.)2005

Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial.

James P Raftery, Guiqing L Yao, Peter Murchie, Neil C Campbell, Lewis D Ritchie

Open access · bronzeAbstract readClinical TrialMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
54.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 138 citations in OpenAlex.

  1. Patient education in the management of coronary heart disease.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Long-term cost effectiveness of cardiac secondary prevention in primary care in the Republic of Ireland and Northern Ireland.The European journal of health economics : HEPAC : health economics in prevention and care · 2017
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Effectiveness of nurse-led heart failure clinic: A systematic review.International journal of nursing sciences · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Optimizing chronic disease management mega-analysis: economic evaluation.Ontario health technology assessment series · 2013
    Review
  16. Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease.The European journal of health economics : HEPAC : health economics in prevention and care · 2012
    Article
  17. Chronic disease management in Sub-Saharan Africa: whose business is it?International journal of environmental research and public health · 2009
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

James P RafteryHealth Economics Facility, Health Services Management Centre, University of Birmingham, Birmingham B15 2RT. j.p.raftery@bham.ac.uk
Guiqing L Yao
Peter Murchie
Neil C Campbell
Lewis D Ritchie
University of Aberdeen · GBUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo establish the cost effectiveness of nurse led secondary prevention clinics for coronary heart disease based on four years' follow up of a randomised controlled trial.

designCost effectiveness analysis.

setting19 general practices in north east Scotland.

participants1343 patients (673 in intervention group and 670 in control group, as originally randomised) aged under 80 years with a diagnosis of coronary heart disease but without terminal illness or dementia and not housebound.

interventionNurse led clinics to promote medical and lifestyle components of secondary prevention.

main outcome measuresCosts of clinics; overall costs to health service; and cost per life year and per quality adjusted life year (QALY) gained, expressed as incremental gain in intervention group compared with control group.

resultsThe cost of the intervention (clinics and drugs) was 136 pounds sterling (254 dollars; 195 euros) per patient higher (1998-9 prices) in the intervention group, but the difference in other NHS costs, although lower for the intervention group, was not statistically significant. Overall, 28 fewer deaths occurred in the intervention group leading to a gain in mean life years per patient of 0.110 and of 0.124 QALYs. The incremental cost per life year saved was 1236 pounds sterling and that per QALY was 1097 pounds sterling.

conclusionNurse led clinics for the secondary prevention of coronary heart disease in primary care seem to be cost effective compared with most interventions in health care, with the main gains in life years saved.

Indexed as

AdultAgedCoronary DiseaseCost-Benefit AnalysisCost of IllnessFamily PracticeFollow-Up StudiesHospitalizationHumansMiddle AgedQuality-Adjusted Life YearsScotland

Identifiers

PMID15716289
PMCPMC555633
OpenAlexW2129644766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.